LogoThe Hemingway Report
Upgrade
Login
Subscribe
Oliver Buchannon
Steve Duke
The Strong Ones

Mar 27, 2026

•

16 min read

The Strong Ones

Dr. Jessica Gaulton, CEO and Founder of FamilyWell, on partnerships, growth, fundraising and the permission to let go.

Steve Duke
Steve Duke
#87: The Map is Not The Territory

Mar 20, 2026

•

18 min read

#87: The Map is Not The Territory

Understanding evals and the frontier of AI testing in mental health

Steve Duke
Kevin Hou
Steve Duke, +1
#86: AI Outperforms Human Therapists in Text-Based CBT Delivery

Mar 12, 2026

•

9 min read

#86: AI Outperforms Human Therapists in Text-Based CBT Delivery

A ground-breaking Nature Medicine study from Limbic

Steve Duke
Steve Duke
#85: Green Shoots: The 2025 Mental Health Earnings Report

Mar 7, 2026

•

18 min read

#85: Green Shoots: The 2025 Mental Health Earnings Report

Outpatient profitability, rate movement, clinician productivity, valuation divergence and more...

Steve Duke
Steve Duke
#84: All the Harm We Cannot See

Feb 27, 2026

•

18 min read

#84: All the Harm We Cannot See

What we’re getting wrong about AI Safety in Mental Health

Steve Duke
Kevin Hou
Steve Duke, +1

GUIDE

#83: What Investors Mean When They Ask for Validated Outcomes

Feb 20, 2026

•

21 min read

#83: What Investors Mean When They Ask for Validated Outcomes

Moving Beyond Engagement Metrics, with Jennifer Huberty, PhD

Steve Duke
Jennifer Huberty, PhD
Steve Duke, +1

THR Pro

#82: The Innovations That Actually Improve Psychotherapy Outcomes

Jan 24, 2026

•

13 min read

#82: The Innovations That Actually Improve Psychotherapy Outcomes

and the impact that has for mental health businesses

Steve Duke
Steve Duke
#81: Using GenAI to scale personalised exposure therapy

Jan 16, 2026

•

17 min read

#81: Using GenAI to scale personalised exposure therapy

Adam Hutchinson shares learnings from two years of using Gen AI video in mental healthcare

Steve Duke
Steve Duke
#80: 13 Predictions for the Mental Health Market in 2026

Dec 19, 2025

•

25 min read

#80: 13 Predictions for the Mental Health Market in 2026

Based on insights from 25 mental health leaders

Steve Duke
Steve Duke
#79: My plans for Hemingway in 2026

Dec 12, 2025

•

17 min read

#79: My plans for Hemingway in 2026

plus my 2025 review, my Theory of Change, the new Hemingway Hotline, and more!

Steve Duke
Steve Duke
#78: Reflections on Slingshot's Real World Study

Dec 5, 2025

•

12 min read

#78: Reflections on Slingshot's Real World Study

What does it mean to internalise an AI and other important questions...

Steve Duke
Steve Duke
#77: The State of Mental Health Markets in Q4 2025

Nov 28, 2025

•

12 min read

#77: The State of Mental Health Markets in Q4 2025

Private funding down over 50%, public valuations compressed - but smart companies still have paths to capital

Steve Duke
Steve Duke
#76: The Potential of Assistive Relational Intelligence

Nov 21, 2025

•

7 min read

#76: The Potential of Assistive Relational Intelligence

A creative project to build distress tolerance and relational capacity.

Steve Duke
Steve Duke
#75: What the FDA is hearing about mental health AI

Nov 7, 2025

•

11 min read

#75: What the FDA is hearing about mental health AI

What I learned from reading all 31 submissions to the FDA DHAC on AI in Mental Health

Steve Duke
Steve Duke
#74 On AI

Oct 31, 2025

•

16 min read

#74 On AI

Reflections on 8 key issues for those building AI in mental health

Steve Duke
Steve Duke
#73: Why ieso is going API-First

Oct 24, 2025

•

13 min read

#73: Why ieso is going API-First

A conversation with ieso CEO, Kent Tangen

Steve Duke
Steve Duke
#72: Should you build a ChatGPT app?

Oct 17, 2025

•

13 min read

#72: Should you build a ChatGPT app?

The opportunities for mental health businesses

Steve Duke
Steve Duke
#71: Six charts explaining the US mental health market right now

Oct 10, 2025

•

11 min read

#71: Six charts explaining the US mental health market right now

BH visits outpace primary care, teletherapy decline, insurance coverage trends, underserved populations and more...

Steve Duke
Steve Duke
#70 AI Regulatory Realignment: Who wins, who loses?

Oct 3, 2025

•

5 min read

#70 AI Regulatory Realignment: Who wins, who loses?

How are AI regulations changing in the US? How does that influence the market? And what can businesses do about it?

Steve Duke
Steve Duke
#69: What if more therapy isn't the answer?

Sep 26, 2025

•

16 min read

#69: What if more therapy isn't the answer?

Some thoughts on solutions for mild depression and anxiety

Steve Duke
Steve Duke
#68: Improving Mental Health Innovation (with APA Labs)

Sep 19, 2025

•

17 min read

#68: Improving Mental Health Innovation (with APA Labs)

APA's new initiative to support mental health innovation + their upcoming event

Steve Duke
Steve Duke
#67: Insights From The World's Leading Mental Health Accelerator

Sep 12, 2025

•

14 min read

#67: Insights From The World's Leading Mental Health Accelerator

Trends, opportunities, mental health moonshots and the OneMind Accelerator

Steve Duke
Steve Duke
#66: Some thoughts on conversational AI

Sep 5, 2025

•

8 min read

#66: Some thoughts on conversational AI

The moral imperative for mental health organisations to build, better, safer AI Agents, and why time is running out.

Steve Duke
Steve Duke
#65 2025 Earnings

Aug 29, 2025

•

2 min read

#65 2025 Earnings

What can we learn from these 4 public mental health companies?

Steve Duke
Steve Duke
#64: Teaching AI to Care

Aug 15, 2025

•

17 min read

#64: Teaching AI to Care

Limbic CEO Ross Harper on clinical-grade LLMs, AI commercialisation, trust, and the future of Limbic.

Steve Duke
Steve Duke
Load more
The Hemingway Report

The Hemingway Report

The only weekly publication for mental health innovators.


Home

Account

© 2026 The Hemingway Report.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv